查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604751

自处置注射器市场：按适应症、用途和最终用户 - 2025-2030 年全球预测

Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，自处置注射器市场价值为232.8亿美元，预计到2024年将达到259.4亿美元，复合年增长率为11.54%，到2030年将达到500.1亿美元。

自处置注射器是一种专门的医疗设备，旨在防止重复使用，大大降低透过不干净的针头传播感染疾病的风险。使用一次后自动锁定或停用，符合全球医疗安全标准。对安全注射实践的需求推动了对这些注射器的需求，特别是在爱滋病毒和肝炎等感染疾病流行的发展中地区。这些注射器广泛应用于疫苗接种计划、药物管理以及医院和诊所的医疗干预。最终用途范围遍及全球，包括医疗机构、公共卫生组织和疫苗宣传活动。不断增加的政府倡议和不断增加的医疗保健支出是该市场的关键成长要素。此外，持续的 COVID-19 大流行增加了对安全有效的疫苗接种方法的需求，这使其成为自拆卸注射器製造商扩大市场的关键机会。在技​​术进步的推动下，这些注射器具有创新潜力，包括整合用于疫苗管理的数位追踪系统以及透过自动化提高生产效率。然而，市场成长受到高製造成本的挑战，特别是在资源匮乏的环境中，以及对这些设备的医疗保健覆盖和人员培训的需求。医疗保健基础设施的地区差异进一步加剧了市场渗透的复杂性。由于该行业的性质，存在激烈的竞争和监管，许多公司专注于产品差异化并遵守严格的健康准则。环境考量使公司能够透过探索生物分解性材料和开发具有成本效益的製造技术来进行创新。战略机会还包括扩大与政府机构和非政府组织的伙伴关係，以实现更广泛的分发，特别是在服务不足的地区。为了保持竞争力和发展，公司应该专注于升级技术并扩展到医疗保健需求不断增长的新兴市场。

主要市场统计
基准年[2023] 232.8亿美元
预计年份 [2024] 259.4亿美元
预测年份 [2030] 500.1亿美元
复合年增长率（%） 11.54%

市场动态：快速发展的自处置注射器市场的关键市场洞察

供需的动态交互作用正在改变自处置注射器市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 针刺伤和交叉感染的发生率增加
    • 医疗机构明显偏好使用自处置注射器
    • 疫苗接种需求不断成长
  • 市场限制因素
    • 采购成本和原物料成本上升
  • 市场机会
    • 将适用范围扩大到大型宣传活动
    • 自处置注射器的不断进步
  • 市场挑战
    • 对不安全注射方法和后勤挑战的担忧

波特五力：驾驭自处置注射器市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解自动处置注射器市场的外部影响

外部宏观环境因素在塑造自处置注射器市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率：透过自动分析和处理功能了解注射器市场的竞争格局

自动处置注射器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：评估自处置注射器市场中供应商的表现

FPNV定位矩阵是评估自动处置注射器市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製自处置注射器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对自处置注射器市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 针刺伤和交叉感染的发生率增加
      • 医疗保健组织强烈喜欢使用具有自我处置功能的注射器
      • 疫苗接种需求增加
    • 抑制因素
      • 采购成本和原物料成本高
    • 机会
      • 扩大群众应用宣传活动范围
      • 自处置注射器的不断进步
    • 任务
      • 对不安全注射方法和后勤挑战的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 自动处置注射器市场（依适应症）

  • 感染疾病
  • 发炎疾病/自体免疫疾病

第七章自动处置注射器市场：依应用分类

  • 血液收集
  • 药物输送
  • 疫苗接种

第八章自动处置注射器市场：依最终使用者分类

  • 门诊手术中心
  • 诊断实验室
  • 医院

第九章 美洲自动处置注射器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太自处置注射器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲自动处置注射器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AccuPoint by AdvaCare Pharma
  • Al Shifa Medical Products Co.
  • Apple Syringe
  • Becton Dickinson & Company
  • Duopross Meditech Corp.
  • Hindustan Syringes & Medical Devices Ltd
  • Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
  • Injecto A/S
  • Iscon Surgicals Ltd.
  • JMI SYRINGES & MEDICAL DEVICES LTD.
  • Merck KGaA
  • PT Oneject Indonesia
  • Retractable Technologies, Inc.
  • Sanavita Pharmaceuticals GmbH
  • Shandong Zhushi Pharmaceutical Group Co.,Ltd.
  • Shanghai Kohope Medical Devices Co., Ltd.
  • Shenzhen Medis Medical
  • Terumo Corporation
Product Code: MRR-D86B4AA1ED0F

The Auto-disable Syringes Market was valued at USD 23.28 billion in 2023, expected to reach USD 25.94 billion in 2024, and is projected to grow at a CAGR of 11.54%, to USD 50.01 billion by 2030.

Auto-disable syringes are specialized medical devices designed to prevent re-use, thus significantly reducing the risk of spreading infectious diseases through unclean needles. They automatically lock or disable after a single use, aligning with global health safety standards. The necessity for these syringes is driven by the need for safe injection practices, especially in developing regions where infectious diseases like HIV and hepatitis are prevalent. These syringes are widely applied in immunization programs, drug administration, and medical interventions in hospitals and clinics. The end-use scope spans across healthcare facilities, public health organizations, and vaccination campaigns globally. Growing government initiatives and increasing healthcare expenditure are significant growth factors in this market. Additionally, the ongoing COVID-19 pandemic has heightened the demand for secure and efficient vaccination methods, presenting a pivotal opportunity for auto-disable syringe manufacturers to expand their market footprint. Reinforced by technology advancements, these syringes offer potential for innovation such as integrating digital tracking systems for vaccination management and increased production efficiency through automation. However, market growth faces challenges like high production costs, especially in low-resource settings, and the need for spreading awareness and training healthcare workers about these devices. Regional disparities in health infrastructure further complicate market penetration. The industry's nature is intensely competitive and regulated, with numerous players focusing on product differentiation and adherence to stringent health guidelines. Companies can target innovation by exploring biodegradable materials to align with environmental concerns and developing cost-effective manufacturing techniques. Expanding partnerships with government bodies and NGOs for widespread distribution, especially in under-served areas, also represents a strategic opportunity. To maintain competitiveness and growth, businesses should focus on technological upgrades and expanding their reach in emerging markets with increasing healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 23.28 billion
Estimated Year [2024] USD 25.94 billion
Forecast Year [2030] USD 50.01 billion
CAGR (%) 11.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Auto-disable Syringes Market

The Auto-disable Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of needle stick injuries and cross infection
    • Significant preference of healthcare organizations towards the use of auto-disable syringes
    • Increasing demand for immunization coverage
  • Market Restraints
    • High cost of procurement and raw material
  • Market Opportunities
    • Increasing scope in mass application campaign
    • Ongoing advancements in auto-disable syringes
  • Market Challenges
    • Concern regarding unsafe injection practices and logistic challenges

Porter's Five Forces: A Strategic Tool for Navigating the Auto-disable Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Auto-disable Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Auto-disable Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Auto-disable Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Auto-disable Syringes Market

A detailed market share analysis in the Auto-disable Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Auto-disable Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Auto-disable Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Auto-disable Syringes Market

A strategic analysis of the Auto-disable Syringes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auto-disable Syringes Market, highlighting leading vendors and their innovative profiles. These include AccuPoint by AdvaCare Pharma, Al Shifa Medical Products Co., Apple Syringe, Becton Dickinson & Company, Duopross Meditech Corp., Hindustan Syringes & Medical Devices Ltd, Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co., Injecto A/S, Iscon Surgicals Ltd., JMI SYRINGES & MEDICAL DEVICES LTD., Merck KGaA, PT Oneject Indonesia, Retractable Technologies, Inc., Sanavita Pharmaceuticals GmbH, Shandong Zhushi Pharmaceutical Group Co.,Ltd., Shanghai Kohope Medical Devices Co., Ltd., Shenzhen Medis Medical, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Auto-disable Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Infectious Diseases and Inflammatory/Auto-Immune Diseases.
  • Based on Application, market is studied across Blood Collection, Drug Delivery, and Vaccination.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of needle stick injuries and cross infection
      • 5.1.1.2. Significant preference of healthcare organizations towards the use of auto-disable syringes
      • 5.1.1.3. Increasing demand for immunization coverage
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of procurement and raw material
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing scope in mass application campaign
      • 5.1.3.2. Ongoing advancements in auto-disable syringes
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding unsafe injection practices and logistic challenges
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Auto-disable Syringes Market, by Indication

  • 6.1. Introduction
  • 6.2. Infectious Diseases
  • 6.3. Inflammatory/Auto-Immune Diseases

7. Auto-disable Syringes Market, by Application

  • 7.1. Introduction
  • 7.2. Blood Collection
  • 7.3. Drug Delivery
  • 7.4. Vaccination

8. Auto-disable Syringes Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals

9. Americas Auto-disable Syringes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Auto-disable Syringes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Auto-disable Syringes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AccuPoint by AdvaCare Pharma
  • 2. Al Shifa Medical Products Co.
  • 3. Apple Syringe
  • 4. Becton Dickinson & Company
  • 5. Duopross Meditech Corp.
  • 6. Hindustan Syringes & Medical Devices Ltd
  • 7. Hunan Pingan Medical Device Technology Co., Ltd. by Winner Medical Co.
  • 8. Injecto A/S
  • 9. Iscon Surgicals Ltd.
  • 10. JMI SYRINGES & MEDICAL DEVICES LTD.
  • 11. Merck KGaA
  • 12. PT Oneject Indonesia
  • 13. Retractable Technologies, Inc.
  • 14. Sanavita Pharmaceuticals GmbH
  • 15. Shandong Zhushi Pharmaceutical Group Co.,Ltd.
  • 16. Shanghai Kohope Medical Devices Co., Ltd.
  • 17. Shenzhen Medis Medical
  • 18. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. AUTO-DISABLE SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 2. AUTO-DISABLE SYRINGES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTO-DISABLE SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTO-DISABLE SYRINGES MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY INFLAMMATORY/AUTO-IMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTO-DISABLE SYRINGES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES AUTO-DISABLE SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM AUTO-DISABLE SYRINGES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. AUTO-DISABLE SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. AUTO-DISABLE SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023